Daunorubicin Injection

Product Description

We specialize in offering a large selection of 20mgDaunorubicin Injection IP. It is a drug used to treat some cancers, such asKaposi's sarcoma, acute lymphoblastic leukaemia, and acute myeloid leukemia. Itis a member of the anthracycline medication class, which inhibits or stops theproliferation of cancer cells. A healthcare practitioner commonly administers20mg Daunorubicin Injection IP in a hospital or clinic environment. Usually,the provided range is provided once every three to four weeks, however this canchange.

Specification